随着现代科学的发展,一些抗病毒药物的问世以及通过细胞工程和遗传工程技术开发的产品,使肝炎的治疗进入一个新领域,遗憾的是慢性乙型肝炎的治疗至今仍未有令人满意的疗法,特别在抗HBV复制方面,到目前为止,未见有真正能使全部HBV阴转的药物和疗法,因此人们梦寐以求的是寻找一种能够促使HBV标志物阴转的药物。但在临床实践中,其结果仍与人们的期望有距离。目前,经 With the development of modern science, the advent of some antiviral drugs and products developed through cellular engineering and genetic engineering technologies have brought the treatment of hepatitis into a new field. Unfortunately, the treatment of chronic hepatitis B has not yet been satisfactory Therapies, especially in anti-HBV replication, have so far not seen drugs and therapies that truly turn all HBV in the negative, so what people are dreamed of is looking for a drug that can drive the HBV markers to turn negative. However, in clinical practice, the result is still far from people’s expectations. At present, after